The global brain health supplements market is entering a strong growth phase, projected to rise from USD 8.80 billion in 2025 to USD 15.44 billion by 2030 at an 11.9% CAGR (1). Demand is being fuelled by increasing awareness of cognitive health, with memory enhancement products alone expected to account for roughly one-third of the market.
While older adults have traditionally driven this category, particularly amid rising concerns over age-related cognitive decline and conditions like Alzheimer’s disease, the market has broadened significantly. One of the fastest-growing segments is children’s brain health. Parents are increasingly focused on supporting cognitive development during key learning years, favouring safe, non-invasive options. The global kids’ supplement market is expected to reach USD 3.5 billion in 2025 and grow to USD 8.6 billion by 2035, with children aged 5–12 representing over 40% of the category (2). Globally, more than half of parents express concern about their child’s brain health, and claims like “supports brain development” strongly influence purchasing decisions (3).
Within this landscape, innovation is shifting toward scientifically validated, fast-acting solutions. Memophenol™ Kids illustrates this evolution. It is derived from Memophenol™, a patented blend of grape and blueberry polyphenol extracts designed to deliver synergistic action on neuroprotection, antioxidant capacity and bioavailability. The original ingredient has been validated through gold-standard clinical studies in both seniors and students, demonstrating measurable improvements in cognitive performance, as well as in episodic and working memory. Building on this strong evidence base in adults, Activ’Inside has extended its scientific efforts to
the younger population through a new real-world study dedicated to children.
The real-world study demonstrated that a single 150 mg dose improved cognitive performance by 10% within just two hours, confirming earlier findings of rapid benefits seen in students within 90 minutes versus placebo. Supplementation was continued for up to 28 days, and the benefits increased over time, with improvements observed not only in objective performance measures but also in parent-reported outcomes. This type of acute effect is increasingly important as consumers look for both immediate and long-term cognitive support.
Format and usability also play a critical role in adoption. Memophenol™ Kids is offered as a stable powder compatible with gummies, stick packs, capsules, and beverages—formats designed to fit seamlessly into children’s routines. Feedback highlights the importance of this approach: over 80% of children favoured the stick format, underscoring the role of convenience and palatability.
From 2025 onward, the market is expected to expand further, particularly in North America and Europe, where academic performance and mental focus are key parental concerns (4). As science-backed ingredients gain traction, brain health supplements are evolving into a central pillar of preventive and performance-driven nutrition, extending well beyond ageing populations to support cognitive function at every stage of life.
Reference:
- https://www.mordorintelligence.com/industry-reports/brain-health-supplements-market
- https://www.futuremarketinsights.com/reports/pediatrics-supplements-market?utm_source=chatgpt.com
- https://www.nutraingredients.com/News/Promotional-features/Asian-Mothers-perceptions-about-toddler-nutrition-formulas/
- https://www.futuremarketinsights.com/reports/kids-brain-health-supplements-market
